Approval for immulite afp for use with the immulite analyzer and immulite 2000 afp for use with the immulite 2000 analyzer. These devices are indicated for in vitro diagnostic use for the quantitative measurement of alpha-fetoprotein (afp) in either of two contexts: a) serial measurements in human serum to aid in the management of patients with nonseminomatous testicular cancer: or b) measurement in maternal serum and amniotic fluid during gestational weeks 15 through 20 - used in conjunction with ultrasonography or amniography - to aid in detection of fetal open neural tube defects.
Device | IMMULITE/IMMULITE 1000 AFP AND IMMULITE 2000/IMMULITE 2500 AFP |
Classification Name | Kit, Test, Alpha-fetoprotein For Neural Tube Defects |
Generic Name | Kit, Test, Alpha-fetoprotein For Neural Tube Defects |
Applicant | SIEMENS HEALTHCARE DIAGNOSTICS INC. |
Date Received | 2001-02-13 |
Decision Date | 2001-11-09 |
Notice Date | 2001-12-05 |
PMA | P010007 |
Supplement | S |
Product Code | LOK |
Docket Number | 01M-0537 |
Advisory Committee | Immunology |
Expedited Review | No |
Combination Product | No |
Applicant Address | SIEMENS HEALTHCARE DIAGNOSTICS INC. 511 Benedict Ave. tarrytown, NY 10591 |
Summary: | Summary of Safety and Effectiveness |
Labeling: | Labeling Labeling Part 2 |
Approval Order: | Approval Order |
Supplemental Filings
Supplement Number | Date | Supplement Type |
P010007 | | Original Filing |
S017 |
2022-09-15 |
30-day Notice |
S016 | | |
S015 |
2022-02-28 |
30-day Notice |
S014 |
2021-04-14 |
30-day Notice |
S013 |
2020-08-12 |
30-day Notice |
S012 |
2020-07-23 |
30-day Notice |
S011 |
2019-11-25 |
30-day Notice |
S010 |
2018-09-28 |
Real-time Process |
S009 |
2012-05-30 |
135 Review Track For 30-day Notice |
S008 |
2011-12-19 |
135 Review Track For 30-day Notice |
S007 |
2011-08-16 |
30-day Notice |
S006 |
2011-08-08 |
30-day Notice |
S005 |
2011-02-18 |
Real-time Process |
S004 |
2009-11-02 |
Normal 180 Day Track No User Fee |
S003 | | |
S002 |
2003-12-12 |
Real-time Process |
S001 |
2003-01-21 |
Real-time Process |
NIH GUDID Devices